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ThE possibility that cultured keratinocytes produce
endothelins were investigated. The results showed that
cultured keratinocytes derived from normal human
skin produce endothelin-1. Moreover, keratinocyte
endotheHn-1 production was completely inhibited by the
presence of actinomycin D in the medium. As in the case
of endothelial cells, recombinant interleukin-l[ was
capable of promoting endothelin-1 production in
keratinocytes, whereas herapin inhibited it. Thrombin
also inhibited endothelin-1 production. These results in-
dicate that the mechanism of endothelin-1 production in
keratinocytes is slightly different from the mechanism in
vascular endothelial cells.
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Introduction
Endothelin is a peptide that causes potent contrac-
tion of vascular smooth muscle. Endothelin not only
has a potent constricting action on smooth muscle
cells, but appears to promote arachidonic acid me-
tabolism and the production of endothelium-derived
relaxing factor (EDRF). Moreover, its promotion of
fibroblast proliferation has been confirmed in vitro.
Although endothelin was previously thought to be
a specific product of vascular endothelial cells. It has
since been found to be produced by tracheal
epithelial cells and nerve cells in the central nervous
45 system, where it acts as a neurotransmitter.. Re-
cently, the authors proposed that endothelin-1 may
participate as an inflammatory mediator because
endothelin-like immunoreactants or endothelin-1
appeared and increased at the wound surface after
thermal injury. Thus endothelin-1 may be capable
of regulating various cell functions, however, it
is still not clear whether keratinocytes produce
endothelin-1.
In the present study, the authors investigated
endothelin-1 production by cultured human
keratinocytes and the mechanisms regulating it.
Materials and Methods
Keratinocyte cultures: Excess skin obtained during
plastic surgery (in particular skin grafting) was made
available to culture normal human keratinocytes. The
skin was finely cut (4 x 4 mm) and after being
disinfected in 10% providone-iodine solution (Meiji
Seika Co., Tokyo, Japan) for 2 min, it was exposed to
phosphate-buffered saline (PBS, Dainihon Seiyaku
Co., Tokyo, Japan) at ambient temperature for 10 min
containing 0.02% disodium ethylene diamine
tetraacetate (EDTA; Dojin Chemical Co., Tokyo,
Japan). The minced skin was then digested in
Dulbecco’s modified Eagle medium (DME; Gibco
BRL Co., Grand Island, NY) containing 0.25% trypsin
(Gibco BRL) for 18 h at 4C, and washed twice with
PBS. The enzyme-treated skin was stirred for I h in
DME medium containing 20% foetal calf serum
(Gibco BRL), antibiotics (penicillin G, kanamycin
(Meiji Seika) and amphotericin B (Gibco BRL)), was
filtered through a Cell strainer (Becton Dickinson
Japan Co., Tokyo, Japan), and the skin residue was
removed. Thus keratinocytes were obtained from
skin as free cells. The free cell suspension was then
centrifuged at 1200 r.p.m, for 5min at 4C.
Keratinocyte growth medium (KGM, modified MCDB
153 containing EGF, insulin, hydrocortisone and
bovine pituitary extracts, Kurasikiboseki Co., Osaka,
Japan) was added to the cell pellet and mixed to
obtain a homogenous suspension. The keratinocytes
were cultured by the Boyce method, and the me-
dium was exchanged after an initial 24 h of culturing
and every 2 days thereafter until confluence. When
cultured primary keratinocytes had reached conflu-
ence, they were re-suspended by adding PBS con-
taining 0.1% trypsin and EDTA, then passaged by the
same procedure.
Endothelin-1 production experiments: When cul-
tured keratinocytes became confluent in the second
passage, they were re-suspended and seeded at a
density of 5 000 cells/well (2 500 cells/cm’) on to 24-
() 1994 Rapid Communications of Oxford Ltd Mediators of Inflammation. Vol 3. 1994 433H. Inoue et al.
well culture dishes. The cells were cultured at 37C
under conditions of 5% CO2/air and 100% humidity.
One ml ofKGM with several concentrations of drugs
(without drugs and with rlL-l3 (Wako Pure Chemical
Co., Osaka, Japan): 0.1, 1.0 and 5.0 U/ml, thrombin
(Sigma Chemical Co., St Louis, MO); 0.2, 2.0 and
20.0 U/ml, heparin (Sigma); 1.0 and 10.0 U/ml) was
added to similarly cultured cells according to the
experimental schedule shown in Table 1 after they
had reached confluence, and the mixture was incu-
bated at 37C. At the same time, a culture containing
40 nM of actinomycin D (Sigma) in the KGM in
addition to the above drugs, was prepared. The
medium obtained after 24 h of incubation reaction
was centrifuged at 1500 r.p.m, for 10 min at 4C and
stored at-80C until endothelin-1 was measured.
Measurements of endothelin-l: Endothelin-1 was
measured with an endothelin-1 EIA kit purchased
from IBL Co. (Gunma, Japan). The procedure was as
follows. A 96-well microplate pre-coated with
monoclonal endothelin-1 antibody was washed
twice with 0.2 ml of PBS containing 0.05% Tween 20
(wash buffer). The medium as specimens, or various
concentrations of authentic endothelin-1 for calibra-
tion, were added, 0.1 ml per well of the pre-condi-
tioned microplate. The plate was incubated for 18 h
at 4C, and then all of the wells were rinsed six times
with 0.2 ml of wash buffer. The following 0.1 ml of
the 3/.tg/ml peroxidase-conjugated polyclonal
endothelin-1 antibody solution was added to each
well of the microplate. After the plate was again
incubated for 30 min at 37C, each well was washed
six times following the same procedure. Then the
0.1 ml of enzymatic substrates for peroxidase (0.1 M
potassium phosphate buffer, pH 7.0, containing
0.4 mg/ml o-phenylenediamine and 0.3% hydrogen
peroxide) was added to each of the wells of the
reacted plate. After incubating for 15 min at ambient
temperature, the reaction was stopped by adding
0.1 ml of 1 N sulphuric acid. The optimal density of
each well at 492 nm was determined using a plate
reader (Bio-Rad Japan Co., Tokyo, Japan). The
endothelin-1 content of the medium was calculated
by comparison with the calibration curve of authen-
tic endothelin-1. A PC-9801 type DA on-line data
processor (NEC Co., Tokyo, Japan) was used to make
the calculations. This EIA method has good reliability
to 4.8 pg/ml (0.48 pg/well) on the calibration curve
for endothelin-1, but the on-line data processor cal-
culates to less than 4.8 pg/ml. The values less than
4.8 pg/ml were noted as <4.8 pg/ml, even though the
on-line data processor calculates the values less than
4.8 pg/ml. Moreover, the experiments were designed
to examine the effect of serum, thrombin, heparin
and rlL-l on this EIA system. As a consequence,
these biological active substances, or until at least a
20% concentration of serum, did not affect use in
this EIA assay.
Statistical analysis: The statistical significance of the
results was evaluated using Student’s t-test. Values
are expressed as means + SEM.
Results
Endothelin-1 production by keratinocytes: Cultured
human keratinocytes produced endothelin-1. At 24 h
after the start of culture, the endothelin-1 level in the
medium was 23.79 + 0.29 pg/well (n 4). Endothelin-
1 production by keratinocytes was completely inhib-
ited by actinomycin D and could not be detected in
the medium after being cultured for 24 h (Fig. 1).
Regulation of endothelin-1 production in
keratinocytes: Production of endothelin-1 by cul-
tured human keratinocytes in the presence of rIL-1]3
increased dose-dependently. As shown in Fig. 2, the
endothelin-1 levels in the medium were 33.52 + 1.62,
41.65 + 3.58 and 56.84 + 15.40 pg/well at rlL-113 con-
centrations of 0.1, 1.0 and 5.0 U/ml, respectively,
compared with 23.79 + 0.29 pg/well obtained
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Table 1. Experimental schedule
Confluent keratinocytes
The various drugs listed below were added in the KGM
Control rlL-11 Thrombin
With AMD
without AMD
Heparin
The keratinocytes were incubated for 24 h at 37C
The medium was collected as a specimen for assay
aAMD: 40 nM actinomycin D.
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only medium 0.1 U/ml 0,2 U/ml not done
1.0 U/ml 2.0 U/ml 1.0 U/ml
5.0 U/ml 20.0 U/ml 10.0 U/ml
only medium 0.1 U/ml 0.2 U/ml not done
1.0 U/ml 2.0 U/ml 1.0 U/ml
5.0 U/ml 20.0 U/ml 10.0 U/mlEndothelin-1 production by cultured keratinocytes
\J ND
without with
40 nM Actinomycin D
FIG. 1. Production of endothelin-1 (ET-1) from cultured human
keratinocytes. The keratinocytes were incubated for 24 h at37C under5%
COJair condition. Each column represents mean SEM ND: not detect-
able. ***p < 0.001: compared with the value obtained without actinomycin D.
without rIL-lJ (n 4). The response in the presence
of thrombin, however, was different. At low concen-
trations, thrombin decreased endothelin-1 produc-
tion, whereas at high concentrations approximately
the same level of endothelin-1 were produced as
when no thrombin was added, i.e. the levels were
7.74 + 0.50, 14.33 + 3.80 and 27.86 + 2.54 pg/well
respectively (n=4), as shown in Fig 3. The
endothelin-1 content of the medium 24 h after cul-
ture without and with 1.0 and 10.0 U/ml heparin was
23.79 + 0.29, 12.83 + 7.20 and 12.00 + 1.46 pg/well
respectively (n 4), as shown in Fig. 4. The addition
of heparin resulted in dose-dependent inhibition of
endothelin-1 production by keratinocytes. The pres-
ence of actinomycin D, on the other hand, inhibited
endothelin-1 production in all cases (n 4, Figs 1-4).
Discussion
Endothelin-1 was discovered in 1988 and was
initially considered to be a hypertensive peptide
produced only by vascular endothelial cells. Later,
tracheal epithelial cells, renal tubules and mesangial
cells were also found to be capable of producing
endothelin-1. 2,8,9 Thus, in addition to affecting
smooth muscles, endothelin-1 probably has wide-
ranging effects on cells and influences organ func-
tion as a whole.
In the present study the authors used cultured
keratinocytes in an attempt to show that normal
human keratinocytes produce endothelin-1. The
results showed that cultured keratinocytes spon-
taneously produce endothelin-1. Moreover, this
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FIG. 2. Influence of recombinant interleukin 11 (rlL-11) on endothelin-1 (ET-1) production of cultured human keratinocytes. The keratinocytes were incubated
for 24 h at 37C under 5% COJair condition. Each column represents mean +/- SEM. ND: not detectable. <4.8: trace level less than 4.8 pg/ml of minimum
calibration range. **p < 0.01 and ***p < 0.001" compared with the value obtained by control (without rlL-lb).
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FIG. 3. Influence of thrombin on endothelin-1 (ET-1) production of cultured human keratinocytes. The keratinocytes were incubated for 24 h at 37C under
5% COJair condition. Each column represents mean SEM. ND: not detectable. 4.8: trace level less than 4.8 pg/ml of minimum calibration range. **p < 0.01
and ***p < 0.001" compared with the value obtained by control (without thrombin).
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FIG. 4. Influence of heparin on endothelin-1 (ET-1) production of cultured human keratinocytes. The keratinocytes were
incubated for 24 h at 37C under 5% COJair condition. Each column represents mean SEM. ND: not detectable.
**p < 0.01 and ***p < 0.001" compared with the value obtained by control (without heparin).
endothelin-1 production was completely inhibited
by the addition of actinomycin D. This suggests that
endothelin-1, as in the case of vascular endothelial
cells, is not stored within the cells.
In 1991, Bull et al.1 failed to detect the endothelin-
1 production by keratinocytes using the indirect
immunofluorescence technique. Yohn et al.,
11 how-
ever, demonstrated that cultured human
keratinocytes could synthesize endothelin-1 at a rate
of about 22 pg/1 x 106 cells spontaneously at 24 h.
The results we obtained were also about 24 pg/dish
at 24 h in the same culture conditions. We therefore
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investigated the regulation of endothelin-1 synthesis
by keratinocytes on the various bioactive substances.
Cytokines, such as IL-1 and tumour necrosis factor
(TNF), activate endothelial C-kinase or calmodulin,
and promote endothelin-1 gene expression and
endothelin-1 secretion. 12,13 Thrombin enhances
endothelial cell endothelin secretion via inositol
metabolism in a similar manner. TM The results of this
study show that IL-l-mediated endothelin-1 produc-
tion is identical to the response obtained from
endothelial cells. Thus, IL-l-induced endothelin-1
production by keratinocytes may appear to be regu-
lated by the same mechanism found in endothelial
cells. However, the similarity of mechanisms should
be confirmed by the experiment designed to com-
pare the effects of various inhibitors of signal
transduction pathway for IL-1 according to the detail
reports of Katabami et al. 13 including expression of
endothelin converting enzyme or big-endothelin-1
by cultured keratinocytes.
Keratinocytes are a plentiful source of the IL-1.15
Moreover, it is known that IL-1 regulates
keratinocytes function as an autocrine and/or
paracrine mediator. 16 IL-1 release by keratinocytes
can also control the stimulation of prostaglandin
synthesis in arachidonic acid metabolism. 17 Based on
these findings endothelin-1 production may also be
regulated by IL-1 synthesis in keratinocytes.
Thrombin reactivity, however, was different, and low
thrombin concentrations (0.2-2.0 U/ml) decreased
epithelial endothelin-1 production. In simultaneous
comparative studies of vascular endothelial and tra-
cheal epithelial cells, thrombin increased endothelin-
1 production in a dose-dependent manner (data not
shown). Accordingly, these results suggest that the
inhibition mechanism of thrombin mediated
endothelin-1 production in keratinocytes and
endothelial cell may be different. Heparin, on the
other hand, inhibited keratinocyte endothelin-1 pro-
duction. This inhibition was attributed to heparin-
induced inhibition of inositol metabolism and Ca2+
influx, similar to that observed in endothelial cells. 18
The above results demonstrate that bioactive sub-
stances can control the endothelin-1 synthesis by
keratinocytes. In particular, IL-1 can stimulate
endothelin-1 production by keratinocytes, but at
present the role of the endothelin-1 produced is
unclear. In recent studies Yada et al. 19 found that
melanocytes contain large quantities of endothelin-1
receptor and that endothelin-1 could stimulate the
cell proliferation and tyrosinase activity. Yohn et al.n
concluded from the results of their investigation that
end0thelin-1 production by keratinocytes may par-
ticipate in melanocyte proliferation and pigmenta-
tion. The increase in IL-1 mediated endothelin-1
synthesis by keratinocytes suggested the following
possible sequence of events: (1) IL-1 production by
keratinocytes increases in presence to UV radiation,
etc.; 19 (2) this IL-1 stimulates endothelin-1 production
by keratinocytes; and (3) the endothelin-1 promotes
the proliferation or activation of tyrosinase in
melanocytes; and finally (4) these processes may be
a factor in the development of pigmentation in vivo.
However, they also indicated that the mechanism of
endothelin-1 production and secretion differs slightly
from that observed in vascular endothelial cells.
Future detailed studies on the influence of cell differ-
entiation and skin inflammation on endothelin-1
production, including the problems raised by this
study, are required.
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